( 0 1 0 1 O
polyneuropathy 1 15 1 15 B-chronic_disease
, 15 16 15 16 O
organomegaly 17 29 17 29 B-chronic_disease
, 29 30 29 30 O
endocrinopathy 31 45 31 45 B-chronic_disease
, 45 46 45 46 O
monoclonal 47 57 47 57 O
protein 58 65 58 65 O
, 65 66 65 66 O
and 67 70 67 70 O
skin 71 75 71 75 O
changes 76 83 76 83 O
) 83 84 83 84 O

Acute 0 5 85 90 O
active 6 12 91 97 B-chronic_disease
infection 13 22 98 107 I-chronic_disease
requiring 23 32 108 117 O
systemic 33 41 118 126 O
antibiotics 42 53 127 138 B-treatment
, 53 54 138 139 O
antivirals 55 65 140 150 B-treatment
, 65 66 150 151 O
or 67 69 152 154 O
antifungals 70 81 155 166 B-treatment
within 82 88 167 173 O
14 89 91 174 176 B-upper_bound
days 92 96 177 181 I-upper_bound
prior 97 102 182 187 I-upper_bound
to 103 105 188 190 O
first 106 111 191 196 O
dose 112 116 197 201 O

Additional 0 10 202 212 O
Laboratory 11 21 213 223 O
Requirements 22 34 224 236 O
ANC 35 38 237 240 B-clinical_variable
≥1.0 39 43 241 245 O
x 44 45 246 247 I-lower_bound
109 46 49 248 251 I-lower_bound
/ 49 50 251 252 I-lower_bound
L 50 51 252 253 I-lower_bound
Hgb 52 55 254 257 B-clinical_variable
≥8 56 58 258 260 O
g 59 60 261 262 I-lower_bound
/ 60 61 262 263 I-lower_bound
dL(transfusion 61 75 263 277 I-lower_bound
permitted 76 85 278 287 O
) 85 86 287 288 O
Platelet 87 95 289 297 B-clinical_variable
count 96 101 298 303 I-clinical_variable
≥50.0 102 107 304 309 O
x 108 109 310 311 I-lower_bound
109 110 113 312 315 I-lower_bound
/ 113 114 315 316 I-lower_bound
L 114 115 316 317 I-lower_bound

Adequate 0 8 318 326 O
hepatic 9 16 327 334 O
function 17 25 335 343 O
, 25 26 343 344 O
with 27 31 345 349 O
bilirubin 32 41 350 359 B-clinical_variable
< 42 43 360 361 O
2 44 45 362 363 B-upper_bound
times 46 51 364 369 I-upper_bound
the 52 55 370 373 I-upper_bound
upper 56 61 374 379 I-upper_bound
limit 62 67 380 385 I-upper_bound
of 68 70 386 388 I-upper_bound
normal 71 77 389 395 I-upper_bound
( 78 79 396 397 I-upper_bound
ULN 79 82 397 400 I-upper_bound
) 82 83 400 401 I-upper_bound
, 83 84 401 402 O
and 85 88 403 406 O
aspartate 89 98 407 416 B-clinical_variable
aminotransferase 99 115 417 433 I-clinical_variable
( 116 117 434 435 I-clinical_variable
AST 117 120 435 438 I-clinical_variable
) 120 121 438 439 I-clinical_variable
and 122 125 440 443 O
alanine 126 133 444 451 B-clinical_variable
aminotransferase 134 150 452 468 I-clinical_variable
( 151 152 469 470 I-clinical_variable
ALT 152 155 470 473 I-clinical_variable
) 155 156 473 474 I-clinical_variable
< 157 158 475 476 O
3 159 160 477 478 B-upper_bound
times 161 166 479 484 I-upper_bound
ULN 167 170 485 488 I-upper_bound

All 0 3 489 492 O
pts 4 7 493 496 O
must 8 12 497 501 O
be 13 15 502 504 O
counseled 16 25 505 514 O
at 26 28 515 517 O
a 29 30 518 519 O
minimum 31 38 520 527 O
of 39 41 528 530 O
every 42 47 531 536 O
28 48 50 537 539 B-lower_bound
days 51 55 540 544 I-lower_bound
about 56 61 545 550 O
pregnancy 62 71 551 560 B-pregnancy
precautions 72 83 561 572 O
and 84 87 573 576 O
risks 88 93 577 582 O
of 94 96 583 585 O
fetal 97 102 586 591 O
exposure 103 111 592 600 O

All 0 3 601 604 O
pts 4 7 605 608 O
must 8 12 609 613 O
have 13 17 614 618 O
received 18 26 619 627 O
prior 27 32 628 633 B-treatment
lenalidomide 33 45 634 646 I-treatment
therapy 46 53 647 654 I-treatment
and 54 57 655 658 O
been 58 62 659 663 O
determined 63 73 664 674 O
to 74 76 675 677 O
be 77 79 678 680 O
refractory 80 90 681 691 O
, 90 91 691 692 O
relapsed 92 100 693 701 O
, 100 101 701 702 O
or 102 104 703 705 O
intolerant 105 115 706 716 O

Congestive 0 10 717 727 B-chronic_disease
heart 11 16 728 733 I-chronic_disease
failure 17 24 734 741 I-chronic_disease
( 25 26 742 743 O
NYHA 26 30 743 747 B-clinical_variable
class 31 36 748 753 I-clinical_variable
III 37 40 754 757 B-lower_bound
to 41 43 758 760 O
IV 44 46 761 763 B-upper_bound
) 46 47 763 764 O
, 47 48 764 765 O
symptomatic 49 60 766 777 O
ischemia 61 69 778 786 B-chronic_disease
, 69 70 786 787 O
conduction 71 81 788 798 O
abnormalities 82 95 799 812 O
uncontrolled 96 108 813 825 O
by 109 111 826 828 O
conventional 112 124 829 841 O
intervention 125 137 842 854 O
or 138 140 855 857 O
myocardial 141 151 858 868 B-chronic_disease
infarction 152 162 869 879 I-chronic_disease
in 163 165 880 882 O
the 166 169 883 886 O
previous 170 178 887 895 B-upper_bound
six 179 182 896 899 I-upper_bound
months 183 189 900 906 I-upper_bound
prior 190 195 907 912 I-upper_bound
to 196 198 913 915 O
first 199 204 916 921 O
dose 205 209 922 926 O

Contraindication 0 16 927 943 O
to 17 19 944 946 O
any 20 23 947 950 O
of 24 26 951 953 O
the 27 30 954 957 O
required 31 39 958 966 O
concomitant 40 51 967 978 O
drugs 52 57 979 984 O
, 57 58 984 985 O
including 59 68 986 995 O
proton 69 75 996 1002 B-treatment
- 75 76 1002 1003 I-treatment
pump 76 80 1003 1007 I-treatment
inhibitor 81 90 1008 1017 I-treatment
( 91 92 1018 1019 O
e.g. 92 96 1019 1023 O
lansoprazole 97 109 1024 1036 B-treatment
) 109 110 1036 1037 O
, 110 111 1037 1038 O
enteric 112 119 1039 1046 B-treatment
- 119 120 1046 1047 I-treatment
coated 120 126 1047 1053 I-treatment
aspirin 127 134 1054 1061 I-treatment
or 135 137 1062 1064 O
if 138 140 1065 1067 O
a 141 142 1068 1069 O
history 143 150 1070 1077 O
of 151 153 1078 1080 O
prior 154 159 1081 1086 O
thrombotic 160 170 1087 1097 B-chronic_disease
disease 171 178 1098 1105 I-chronic_disease
, 178 179 1105 1106 O
warfarin 180 188 1107 1115 B-treatment
or 189 191 1116 1118 I-treatment
low 192 195 1119 1122 I-treatment
molecular 196 205 1123 1132 I-treatment
weight 206 212 1133 1139 I-treatment
heparin 213 220 1140 1147 I-treatment

CrCl 0 4 1148 1152 B-clinical_variable
≥ 5 6 1153 1154 O
50 7 9 1155 1157 B-lower_bound
mL 10 12 1158 1160 I-lower_bound
/ 12 13 1160 1161 I-lower_bound
min 13 16 1161 1164 I-lower_bound

Current 0 7 1165 1172 O
diagnosis 8 17 1173 1182 O
of 18 20 1183 1185 O
plasma 21 27 1186 1192 B-cancer
cell 28 32 1193 1197 I-cancer
leukemia 33 41 1198 1206 I-cancer

Cytopathologically 0 18 1207 1225 O
or 19 21 1226 1228 O
histologically 22 36 1229 1243 O
confirmed 37 46 1244 1253 O
dx 47 49 1254 1256 O
of 50 52 1257 1259 O
multiple 53 61 1260 1268 B-cancer
myeloma 62 69 1269 1276 I-cancer

ECOG 0 4 1277 1281 B-clinical_variable
PS 5 7 1282 1284 I-clinical_variable
of 8 10 1285 1287 O
0 11 12 1288 1289 B-lower_bound
- 12 13 1289 1290 O
2 13 14 1290 1291 B-upper_bound

Exposure 0 8 1292 1300 O
to 9 11 1301 1303 O
any 12 15 1304 1307 O
prior 16 21 1308 1313 B-treatment
chemotherapy 22 34 1314 1326 I-treatment
, 34 35 1326 1327 O
steroid 36 43 1328 1335 B-treatment
use 44 47 1336 1339 O
, 47 48 1339 1340 O
or 49 51 1341 1343 O
other 52 57 1344 1349 O
myeloma 58 65 1350 1357 B-treatment
treatment 66 75 1358 1367 I-treatment
within 76 82 1368 1374 O
14 83 85 1375 1377 B-upper_bound
days 86 90 1378 1382 I-upper_bound
prior 91 96 1383 1388 I-upper_bound
to 97 99 1389 1391 O
first 100 105 1392 1397 O
dose 106 110 1398 1402 O
. 110 111 1402 1403 O
Pts 112 115 1404 1407 O
currently 116 125 1408 1417 O
on 126 128 1418 1420 O
long 129 133 1421 1425 O
term 134 138 1426 1430 O
steroids 139 147 1431 1439 B-treatment
do 148 150 1440 1442 O
not 151 154 1443 1446 O
require 155 162 1447 1454 O
any 163 166 1455 1458 O
washout 167 174 1459 1466 O
period 175 181 1467 1473 O
. 181 182 1473 1474 O
in 183 185 1475 1477 O
addition 186 194 1478 1486 O
, 194 195 1486 1487 O
steroid 196 203 1488 1495 O
use 204 207 1496 1499 O
for 208 211 1500 1503 O
spinal 212 218 1504 1510 B-chronic_disease
cord 219 223 1511 1515 I-chronic_disease
compression 224 235 1516 1527 I-chronic_disease
is 236 238 1528 1530 O
permitted 239 248 1531 1540 O
and 249 252 1541 1544 O
does 253 257 1545 1549 O
not 258 261 1550 1553 O
require 262 269 1554 1561 O
a 270 271 1562 1563 O
washout 272 279 1564 1571 O
period 280 286 1572 1578 O

FCBP 0 4 1579 1583 O
must 5 9 1584 1588 O
agree 10 15 1589 1594 O
to 16 18 1595 1597 O
ongoing 19 26 1598 1605 O
pregnancy 27 36 1606 1615 B-pregnancy
testing 37 44 1616 1623 O

FCBP 0 4 1624 1628 O
must 5 9 1629 1633 O
have 10 14 1634 1638 O
a 15 16 1639 1640 O
negative 17 25 1641 1649 B-pregnancy
serum 26 31 1650 1655 I-pregnancy
or 32 34 1656 1658 I-pregnancy
urine 35 40 1659 1664 I-pregnancy
pregnancy 41 50 1665 1674 I-pregnancy
test 51 55 1675 1679 O
and 56 59 1680 1683 O
agree 60 65 1684 1689 B-contraception_consent
to 66 68 1690 1692 I-contraception_consent
birth 69 74 1693 1698 I-contraception_consent
control 75 82 1699 1706 I-contraception_consent

Known 0 5 1707 1712 O
allergies 6 15 1713 1722 O
to 16 18 1723 1725 O
carfilzomib 19 30 1726 1737 B-allergy_name
or 31 33 1738 1740 O
Captisol 34 42 1741 1749 B-allergy_name

Life 0 4 1750 1754 B-clinical_variable
expectancy 5 15 1755 1765 I-clinical_variable
of 16 18 1766 1768 O
more 19 23 1769 1773 O
than 24 28 1774 1778 O
3 29 30 1779 1780 B-lower_bound
months 31 37 1781 1787 I-lower_bound

Major 0 5 1788 1793 B-treatment
surgery 6 13 1794 1801 I-treatment
within 14 20 1802 1808 O
21 21 23 1809 1811 B-upper_bound
days 24 28 1812 1816 I-upper_bound
prior 29 34 1817 1822 I-upper_bound
to 35 37 1823 1825 O
first 38 43 1826 1831 O
dose 44 48 1832 1836 O

Male 0 4 1837 1841 B-gender
pts 5 8 1842 1845 O
can 9 12 1846 1849 O
not 12 15 1849 1852 O
donate 16 22 1853 1859 O
semen 23 28 1860 1865 O
or 29 31 1866 1868 O
sperm 32 37 1869 1874 O
while 38 43 1875 1880 O
taking 44 50 1881 1887 O
pomalidomide 51 63 1888 1900 B-treatment
and 64 67 1901 1904 O
for 68 71 1905 1908 O
28 72 74 1909 1911 B-upper_bound
days 75 79 1912 1916 I-upper_bound
after 80 85 1917 1922 O
completing 86 96 1923 1933 O
the 97 100 1934 1937 O
study 101 106 1938 1943 O

Male 0 4 1944 1948 B-gender
pts 5 8 1949 1952 O
must 9 13 1953 1957 O
agree 14 19 1958 1963 O
to 20 22 1964 1966 O
never 23 28 1967 1972 O
have 29 33 1973 1977 O
unprotected 34 45 1978 1989 O
sexual 46 52 1990 1996 O
contact 53 60 1997 2004 O
with 61 65 2005 2009 O
a 66 67 2010 2011 O
female 68 74 2012 2018 B-gender
who 75 78 2019 2022 O
can 79 82 2023 2026 O
become 83 89 2027 2033 B-pregnancy
pregnant 90 98 2034 2042 I-pregnancy
and 99 102 2043 2046 O
must 103 107 2047 2051 O
agree 108 113 2052 2057 O
to 114 116 2058 2060 O
either 117 123 2061 2067 O
completely 124 134 2068 2078 O
abstain 135 142 2079 2086 O
from 143 147 2087 2091 O
sexual 148 154 2092 2098 O
contact 155 162 2099 2106 O
with 163 167 2107 2111 O
females 168 175 2112 2119 B-gender
who 176 179 2120 2123 O
are 180 183 2124 2127 B-pregnancy
pregnant 184 192 2128 2136 I-pregnancy
or 193 195 2137 2139 O
are 196 199 2140 2143 O
able 200 204 2144 2148 B-pregnancy
to 205 207 2149 2151 I-pregnancy
become 208 214 2152 2158 I-pregnancy
pregnant 215 223 2159 2167 I-pregnancy

Measurable 0 10 2168 2178 B-cancer
disease 11 18 2179 2186 I-cancer

POEMS 0 5 2187 2192 B-chronic_disease
syndrome 6 14 2193 2201 I-chronic_disease

Pregnant 0 8 2202 2210 B-pregnancy

Pts 0 3 2211 2214 O
in 4 6 2215 2217 O
whom 7 11 2218 2222 O
the 12 15 2223 2226 O
required 16 24 2227 2235 O
program 25 32 2236 2243 O
of 33 35 2244 2246 O
oral 36 40 2247 2251 O
and 41 44 2252 2255 O
intravenous 45 56 2256 2267 O
fluid 57 62 2268 2273 O
hydration 63 72 2274 2283 O
is 73 75 2284 2286 O
contraindicated 76 91 2287 2302 O
, 91 92 2302 2303 O
e.g. 93 97 2304 2308 O
due 98 101 2309 2312 O
to 102 104 2313 2315 O
pre 105 108 2316 2319 O
- 108 109 2319 2320 O
existing 109 117 2320 2328 O
pulmonary 118 127 2329 2338 O
, 127 128 2338 2339 O
cardiac 129 136 2340 2347 O
, 136 137 2347 2348 O
or 138 140 2349 2351 O
renal 141 146 2352 2357 O
impairment 147 157 2358 2368 I-chronic_disease

Pts 0 3 2369 2372 O
may 4 7 2373 2376 O
receive 8 15 2377 2384 O
RBC 16 19 2385 2388 B-treatment
or 20 22 2389 2391 O
platelet 23 31 2392 2400 B-treatment
transfusions 32 44 2401 2413 I-treatment
, 44 45 2413 2414 O
if 46 48 2415 2417 O
clinically 49 59 2418 2428 O
indicated 60 69 2429 2438 O
, 69 70 2438 2439 O
in 71 73 2440 2442 O
accordance 74 84 2443 2453 O
with 85 89 2454 2458 O
institutional 90 103 2459 2472 O
guidelines 104 114 2473 2483 O

Pts 0 3 2484 2487 O
must 4 8 2488 2492 O
agree 9 14 2493 2498 O
to 15 17 2499 2501 O
take 18 22 2502 2506 O
enteric 23 30 2507 2514 B-treatment
- 30 31 2514 2515 I-treatment
coated 31 37 2515 2521 I-treatment
aspirin 38 45 2522 2529 I-treatment
81 46 48 2530 2532 O
mg 49 51 2533 2535 O
orally 52 58 2536 2542 O
daily 59 64 2543 2548 O
, 64 65 2548 2549 O
or 66 68 2550 2552 O
if 69 71 2553 2555 O
history 72 79 2556 2563 O
of 80 82 2564 2566 O
prior 83 88 2567 2572 O
thrombotic 89 99 2573 2583 B-chronic_disease
disease 100 107 2584 2591 I-chronic_disease
, 107 108 2591 2592 O
must 109 113 2593 2597 O
be 114 116 2598 2600 O
fully 117 122 2601 2606 O
anticoagulated 123 137 2607 2621 O
with 138 142 2622 2626 O
warfarin 143 151 2627 2635 B-treatment
( 152 153 2636 2637 O
INR 153 156 2637 2640 B-clinical_variable
2 157 158 2641 2642 B-lower_bound
- 158 159 2642 2643 O
3 159 160 2643 2644 B-upper_bound
) 160 161 2644 2645 O
or 162 164 2646 2648 O
be 165 167 2649 2651 O
treated 168 175 2652 2659 O
with 176 180 2660 2664 O
full 181 185 2665 2669 O
- 185 186 2669 2670 O
dose 186 190 2670 2674 O
, 190 191 2674 2675 O
low 192 195 2676 2679 B-treatment
molecular 196 205 2680 2689 I-treatment
weight 206 212 2690 2696 I-treatment
heparin 213 220 2697 2704 I-treatment
, 220 221 2704 2705 O
as 222 224 2706 2708 O
if 225 227 2709 2711 O
to 228 230 2712 2714 O
treat 231 236 2715 2720 O
deep 237 241 2721 2725 B-chronic_disease
venous 242 248 2726 2732 I-chronic_disease
thrombosis 249 259 2733 2743 I-chronic_disease
( 260 261 2744 2745 I-chronic_disease
DVT)/pulmonary 261 275 2745 2759 I-chronic_disease
embolism 276 284 2760 2768 I-chronic_disease
( 285 286 2769 2770 I-chronic_disease
PE)at 286 291 2770 2775 I-chronic_disease
the 292 295 2776 2779 O
investigator 296 308 2780 2792 O
's 308 310 2792 2794 O
discretion 311 321 2795 2805 O

Pts 0 3 2806 2809 O
must 4 8 2810 2814 O
be 9 11 2815 2817 O
≥ 12 13 2818 2819 O
18 14 16 2820 2822 B-lower_bound
years 17 22 2823 2828 I-lower_bound
of 23 25 2829 2831 O
age 26 29 2832 2835 B-age

Pts 0 3 2836 2839 O
receiving 4 13 2840 2849 O
active 14 20 2850 2856 B-treatment
treatment 21 30 2857 2866 I-treatment
or 31 33 2867 2869 O
intervention 34 46 2870 2882 O
for 47 50 2883 2886 O
any 51 54 2887 2890 O
other 55 60 2891 2896 O
malignancy 61 71 2897 2907 B-cancer
or 72 74 2908 2910 O
pts 75 78 2911 2914 O
who 79 82 2915 2918 O
, 82 83 2918 2919 O
at 84 86 2920 2922 O
the 87 90 2923 2926 O
Investigator 91 103 2927 2939 O
's 103 105 2939 2941 O
discretion 106 116 2942 2952 O
, 116 117 2952 2953 O
may 118 121 2954 2957 O
require 122 129 2958 2965 O
active 130 136 2966 2972 O
treatment 137 146 2973 2982 O
or 147 149 2983 2985 O
intervention 150 162 2986 2998 O
for 163 166 2999 3002 O
any 167 170 3003 3006 O
other 171 176 3007 3012 O
malignancy 177 187 3013 3023 O
within 188 194 3024 3030 O
8 195 196 3031 3032 B-upper_bound
months 197 203 3033 3039 I-upper_bound
of 204 206 3040 3042 O
starting 207 215 3043 3051 O
study 216 221 3052 3057 O
treatment 222 231 3058 3067 O

Pts 0 3 3068 3071 O
who 4 7 3072 3075 O
have 8 12 3076 3080 O
received 13 21 3081 3089 O
prior 22 27 3090 3095 O
treatment 28 37 3096 3105 O
with 38 42 3106 3110 O
both 43 47 3111 3115 O
carfilzomib 48 59 3116 3127 B-treatment
& 60 61 3128 3129 O
pomalidomide 62 74 3130 3142 B-treatment
( 75 76 3143 3144 O
Phase 76 81 3144 3149 O
I 82 83 3150 3151 O
only 84 88 3152 3156 O
) 88 89 3156 3157 O

Pts 0 3 3158 3161 O
who 4 7 3162 3165 O
have 8 12 3166 3170 O
received 13 21 3171 3179 O
prior 22 27 3180 3185 O
treatment 28 37 3186 3195 O
with 38 42 3196 3200 O
carfilzomib 43 54 3201 3212 B-treatment
( 55 56 3213 3214 O
Phase 56 61 3214 3219 O
II 62 64 3220 3222 O
only 65 69 3223 3227 O
) 69 70 3227 3228 O

Pts 0 3 3229 3232 O
who 4 7 3233 3236 O
have 8 12 3237 3241 O
received 13 21 3242 3250 O
prior 22 27 3251 3256 B-treatment
treatment 28 37 3257 3266 I-treatment
with 38 42 3267 3271 O
pomalidomide 43 55 3272 3284 B-treatment
( 56 57 3285 3286 I-treatment
Phase 57 62 3286 3291 I-treatment
II 63 65 3292 3294 I-treatment
only 66 70 3295 3299 I-treatment
) 70 71 3299 3300 I-treatment

Pts 0 3 3301 3304 O
with 4 8 3305 3309 O
known 9 14 3310 3315 O
sensitivity 15 26 3316 3327 O
to 27 29 3328 3330 O
any 30 33 3331 3334 O
immunomodulatory 34 50 3335 3351 B-allergy_name
drugs 51 56 3352 3357 I-allergy_name
( 57 58 3358 3359 I-allergy_name
IMiDs 58 63 3359 3364 I-allergy_name
) 63 64 3364 3365 I-allergy_name

Pts 0 3 3366 3369 O
with 4 8 3370 3374 O
primary 9 16 3375 3382 B-cancer
systemic 17 25 3383 3391 I-cancer
amyloidosis 26 37 3392 3403 I-cancer

Radiation 0 9 3404 3413 B-treatment
therapy 10 17 3414 3421 I-treatment
within 18 24 3422 3428 O
14 25 27 3429 3431 B-upper_bound
days 28 32 3432 3436 I-upper_bound
prior 33 38 3437 3442 I-upper_bound
to 39 41 3443 3445 O
first 42 47 3446 3451 O
dose 48 52 3452 3456 O

Relapsed 0 8 3457 3465 O
or 9 11 3466 3468 O
refractory 12 22 3469 3479 O
to 23 25 3480 3482 O
the 26 29 3483 3486 O
most 30 34 3487 3491 O
recently 35 43 3492 3500 O
received 44 52 3501 3509 O
therapy 53 60 3510 3517 B-treatment

Screening 0 9 3518 3527 O
ANC 10 13 3528 3531 B-clinical_variable
should 14 20 3532 3538 O
be 21 23 3539 3541 O
independent 24 35 3542 3553 O
of 36 38 3554 3556 O
granulocyte 39 50 3557 3568 O
- 50 51 3568 3569 O
and 51 54 3569 3572 O
granulocyte 55 66 3573 3584 O
/ 66 67 3584 3585 O
macrophage 67 77 3585 3595 O
colony 78 84 3596 3602 O
stimulating 85 96 3603 3614 O
factor 97 103 3615 3621 O
( 104 105 3622 3623 O
G 105 106 3623 3624 O
- 106 107 3624 3625 O
CSF 107 110 3625 3628 O
and 111 114 3629 3632 O
GM 115 117 3633 3635 O
- 117 118 3635 3636 O
CSF 118 121 3636 3639 O
) 121 122 3639 3640 O
support 123 130 3641 3648 O
for 131 134 3649 3652 O
at 135 137 3653 3655 O
least 138 143 3656 3661 O
1 144 145 3662 3663 B-lower_bound
week 146 150 3664 3668 I-lower_bound
and 151 154 3669 3672 O
of 155 157 3673 3675 O
pegylated 158 167 3676 3685 O
G 168 169 3686 3687 O
- 169 170 3687 3688 O
CSF 170 173 3688 3691 O
for 174 177 3692 3695 O
at 178 180 3696 3698 O
least 181 186 3699 3704 O
2 187 188 3705 3706 B-lower_bound
weeks 189 194 3707 3712 I-lower_bound

Screening 0 9 3713 3722 O
platelet 10 18 3723 3731 B-clinical_variable
count 19 24 3732 3737 I-clinical_variable
should 25 31 3738 3744 O
be 32 34 3745 3747 O
independent 35 46 3748 3759 O
of 47 49 3760 3762 O
platelet 50 58 3763 3771 B-treatment
transfusions 59 71 3772 3784 I-treatment
for 72 75 3785 3788 O
at 76 78 3789 3791 O
least 79 84 3792 3797 O
2 85 86 3798 3799 B-lower_bound
weeks 87 92 3800 3805 I-lower_bound

Serious 0 7 3806 3813 O
psychiatric 8 19 3814 3825 B-chronic_disease
or 20 22 3826 3828 O
medical 23 30 3829 3836 B-chronic_disease
conditions 31 41 3837 3847 I-chronic_disease
that 42 46 3848 3852 O
could 47 52 3853 3858 O
interfere 53 62 3859 3868 O
with 63 67 3869 3873 O
treatment 68 77 3874 3883 B-treatment

Serum 0 5 3884 3889 B-clinical_variable
M 6 7 3890 3891 I-clinical_variable
- 7 8 3891 3892 I-clinical_variable
protein 8 15 3892 3899 I-clinical_variable
≥ 16 17 3900 3901 O
0.5 18 21 3902 3905 B-lower_bound
g 22 23 3906 3907 I-lower_bound
/ 23 24 3907 3908 I-lower_bound
dL 24 26 3908 3910 I-lower_bound
Urine 27 32 3911 3916 B-clinical_variable
Bence 33 38 3917 3922 I-clinical_variable
Jones 39 44 3923 3928 I-clinical_variable
protein 45 52 3929 3936 I-clinical_variable
≥ 53 54 3937 3938 O
200 55 58 3939 3942 B-lower_bound
mg/24 59 64 3943 3948 I-lower_bound
hr 65 67 3949 3951 I-lower_bound
Elevated 68 76 3952 3960 O
Free 77 81 3961 3965 O
Light 82 87 3966 3971 O
Chain 88 93 3972 3977 O
as 94 96 3978 3980 O
per 97 100 3981 3984 O
IMWG 101 105 3985 3989 O
criteria 106 114 3990 3998 O
, 114 115 3998 3999 O
and 116 119 4000 4003 O
abnormal 120 128 4004 4012 O
ratio 129 134 4013 4018 O

Significant 0 11 4019 4030 O
neuropathy 12 22 4031 4041 B-chronic_disease
( 23 24 4042 4043 O
Grade 24 29 4043 4048 B-chronic_disease
3 30 31 4049 4050 I-chronic_disease
, 31 32 4050 4051 O
Grade 33 38 4052 4057 B-chronic_disease
4 39 40 4058 4059 I-chronic_disease
, 40 41 4059 4060 O
or 42 44 4061 4063 O
Grade 45 50 4064 4069 B-chronic_disease
2 51 52 4070 4071 I-chronic_disease
with 53 57 4072 4076 O
pain 58 62 4077 4081 O
) 62 63 4081 4082 O
at 64 66 4083 4085 O
the 67 70 4086 4089 O
time 71 75 4090 4094 O
of 76 78 4095 4097 O
the 79 82 4098 4101 O
first 83 88 4102 4107 O
dose 89 93 4108 4112 O
and/or 94 100 4113 4119 O
within 101 107 4120 4126 O
14 108 110 4127 4129 B-upper_bound
days 111 115 4130 4134 I-upper_bound
before 116 122 4135 4141 O
enrollment 123 133 4142 4152 O

Uric 0 4 4153 4157 B-clinical_variable
acid 5 9 4158 4162 I-clinical_variable
must 10 14 4163 4167 O
be 15 17 4168 4170 O
within 18 24 4171 4177 O
laboratory 25 35 4178 4188 O
normal 36 42 4189 4195 O
range 43 48 4196 4201 O

Use 0 3 4202 4205 O
of 4 6 4206 4208 O
any 7 10 4209 4212 O
other 11 16 4213 4218 O
experimental 17 29 4219 4231 B-treatment
drug 30 34 4232 4236 I-treatment
or 35 37 4237 4239 O
therapy 38 45 4240 4247 B-treatment
within 46 52 4248 4254 O
21 53 55 4255 4257 B-upper_bound
days 56 60 4258 4262 I-upper_bound
prior 61 66 4263 4268 I-upper_bound
to 67 69 4269 4271 O
first 70 75 4272 4277 O
dose 76 80 4278 4282 O

Waldenström 0 11 4283 4294 B-chronic_disease
's 11 13 4294 4296 I-chronic_disease
macroglobulinemia 14 31 4297 4314 I-chronic_disease

lactating 0 9 4315 4324 O
females 10 17 4325 4332 B-gender

